Price history
¥2,550Latest-4.7%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 19
PER
38.11How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
0.78How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
-31.9%Earning power. A figure above 10% is generally considered good.Dividend yield
0.0%The annual dividend as a percentage of the share price.Market capitalization
¥12bnShare price × number of shares. The value of the entire company.Equity ratio
53.9%The proportion of assets funded by money that does not have to be repaid.Operating margin
2.1%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
-2.9%The average annual growth in sales over the past three years.What to watch next
Progress toward adoption and contract manufacturing following the start of sample provision of CO2-absorbing amine compounds for DAC (evaluation to commercialization)
2026〜Impact HighLikelihood Medium
Establishment of mass production and commercial-scale manufacturing of CO2-absorbing amine compounds at the gas-phase plant (completion of laboratory studies to start-up of mass production)
2027〜Impact HighLikelihood Medium
Changes in capital policy and transaction terms associated with the share exchange with Sumitomo Chemical, under which the company will become a wholly owned subsidiary (effective date scheduled for 1 August 2026)
2026-08Impact MediumLikelihood Medium
Stabilization of operations and earnings improvement following capital investment, including the renewal of aging fine chemical production equipment (progress in absorbing or passing through higher costs)
2026〜2027Impact MediumLikelihood Medium
Renewed acceleration toward the ROIC target of 8% and a shorter cash conversion cycle (quantifiable recovery in capital efficiency)
Impact MediumLikelihood Low
What to watch next
Who owns itTop holders total 68.3%
Listed holders 68.3%Everyone else 31.7%
SUMITOMO CHEMICAL COMPANY,LIMITED55.85%
Kinki Sangyo Credit Union4.91%
Taneda Osamu (種田 修)2.11%
阪本 重治1.28%
広栄化学社員持株会1.10%
丸石化学品株式会社0.69%
高石 文夫0.68%
山田 晃0.68%
2 other listed holders1.02%
| Holder | Ownership (%) |
|---|---|
| SUMITOMO CHEMICAL COMPANY,LIMITED | 55.85 |
| Kinki Sangyo Credit Union | 4.91 |
| Taneda Osamu (種田 修) | 2.11 |
| 阪本 重治 | 1.28 |
| 広栄化学社員持株会 | 1.10 |
| 丸石化学品株式会社 | 0.69 |
| 高石 文夫 | 0.68 |
| 山田 晃 | 0.68 |
| 2 other listed holders | 1.02 |
This company's documents
Filings
Timely disclosures
- 2026-07-29Notice Regarding the Delisting of Our Shares
- 2026-06-25Notice Concerning the Cancellation of Treasury Shares
- 2026-06-25Partial Amendment to “Other Matters Subject to Electronic Provision for the 165th Annual General Meeting of Shareholders (Matters Omitted from the Documents Delivered) (1)”
- 2026-06-24(Amendment) Statutory Advance Disclosure Document (Share Exchange) (SUMITOMO CHEMICAL COMPANY,LIMITED)
- 2026-06-10Statutory Prior Disclosure Documents (Share Exchange) (SUMITOMO CHEMICAL COMPANY,LIMITED)
- 2026-06-01Notice of Independent Officer Status
- 2026-06-012026 Annual General Meeting of Shareholders: Other Matters Subject to Electronic Provision Measures (Matters Omitted from Documents Delivered) (1)
- 2026-06-01Notice of Convocation of the 2026 Annual General Meeting of Shareholders and Meeting Materials
6 more
- 2026-05-13Notice regarding the execution of a share exchange agreement for SUMITOMO CHEMICAL COMPANY,LIMITED to make KOEI CHEMICAL COMPANY,LIMITED a wholly owned subsidiary (simplified share exchange)
- 2026-05-13Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Non-consolidated)
- 2026-05-13Matters Concerning Controlling Shareholders
- 2026-05-13Notice of Changes to Directors
- 2026-04-21Notice Regarding Revisions to the Earnings Forecast for the Fiscal Year Ending March 2026
- 2026-03-31Notice Concerning the Recognition of an Impairment Loss and Revisions to the Earnings Forecast for the Fiscal Year Ending March 2026